東和薬品の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2025/05/20 | 2,831 | 2,875 | 2,819 | 2,837 | +31 | +1.1% | 186,800 |
2025/05/19 | 2,808 | 2,833 | 2,786 | 2,806 | -19 | -0.7% | 217,300 |
2025/05/16 | 2,655 | 2,837 | 2,655 | 2,825 | +370 | +15.1% | 584,100 |
2025/05/15 | 2,550 | 2,579 | 2,392 | 2,455 | -145 | -5.6% | 339,100 |
2025/05/14 | 2,645 | 2,645 | 2,550 | 2,600 | -54 | -2% | 132,000 |
2025/05/13 | 2,636 | 2,657 | 2,608 | 2,654 | +41 | +1.6% | 112,100 |
2025/05/12 | 2,664 | 2,673 | 2,575 | 2,613 | -41 | -1.5% | 101,200 |
2025/05/09 | 2,637 | 2,660 | 2,615 | 2,654 | +23 | +0.9% | 70,700 |
2025/05/08 | 2,675 | 2,681 | 2,608 | 2,631 | +6 | +0.2% | 119,700 |
2025/05/07 | 2,637 | 2,644 | 2,619 | 2,625 | -12 | -0.5% | 66,800 |
2025/05/02 | 2,648 | 2,672 | 2,628 | 2,637 | +17 | +0.6% | 91,400 |
2025/05/01 | 2,645 | 2,663 | 2,618 | 2,620 | -24 | -0.9% | 50,300 |
2025/04/30 | 2,637 | 2,656 | 2,621 | 2,644 | +18 | +0.7% | 83,700 |
2025/04/28 | 2,620 | 2,659 | 2,613 | 2,626 | +8 | +0.3% | 121,100 |
2025/04/25 | 2,601 | 2,633 | 2,598 | 2,618 | +21 | +0.8% | 78,500 |
2025/04/24 | 2,594 | 2,628 | 2,588 | 2,597 | +3 | +0.1% | 58,300 |
2025/04/23 | 2,584 | 2,612 | 2,572 | 2,594 | +32 | +1.2% | 105,900 |
2025/04/22 | 2,535 | 2,562 | 2,528 | 2,562 | +38 | +1.5% | 51,600 |
2025/04/21 | 2,531 | 2,541 | 2,508 | 2,524 | -24 | -0.9% | 42,300 |
2025/04/18 | 2,514 | 2,548 | 2,509 | 2,548 | +63 | +2.5% | 64,100 |
2025/04/17 | 2,492 | 2,494 | 2,468 | 2,485 | -8 | -0.3% | 48,700 |
2025/04/16 | 2,470 | 2,493 | 2,446 | 2,493 | +22 | +0.9% | 87,100 |
2025/04/15 | 2,483 | 2,498 | 2,470 | 2,471 | +32 | +1.3% | 144,800 |
2025/04/14 | 2,430 | 2,469 | 2,422 | 2,439 | +27 | +1.1% | 76,200 |
2025/04/11 | 2,426 | 2,430 | 2,379 | 2,412 | -78 | -3.1% | 105,800 |
2025/04/10 | 2,525 | 2,525 | 2,463 | 2,490 | +123 | +5.2% | 103,200 |
2025/04/09 | 2,408 | 2,417 | 2,355 | 2,367 | -91 | -3.7% | 120,900 |
2025/04/08 | 2,436 | 2,458 | 2,404 | 2,458 | +89 | +3.8% | 179,000 |
2025/04/07 | 2,330 | 2,414 | 2,298 | 2,369 | -161 | -6.4% | 267,300 |
2025/04/04 | 2,542 | 2,573 | 2,496 | 2,530 | -57 | -2.2% | 170,300 |
2025/04/03 | 2,550 | 2,602 | 2,532 | 2,587 | -43 | -1.6% | 167,600 |
2025/04/02 | 2,701 | 2,709 | 2,630 | 2,630 | -70 | -2.6% | 99,000 |
2025/04/01 | 2,692 | 2,715 | 2,688 | 2,700 | +21 | +0.8% | 84,300 |
2025/03/31 | 2,720 | 2,729 | 2,674 | 2,679 | -64 | -2.3% | 198,600 |
2025/03/28 | 2,771 | 2,779 | 2,743 | 2,743 | -55 | -2% | 82,800 |
2025/03/27 | 2,775 | 2,798 | 2,765 | 2,798 | -4 | -0.1% | 84,700 |
2025/03/26 | 2,802 | 2,815 | 2,791 | 2,802 | +2 | +0.1% | 86,600 |
2025/03/25 | 2,790 | 2,812 | 2,771 | 2,800 | +10 | +0.4% | 71,700 |
2025/03/24 | 2,820 | 2,820 | 2,750 | 2,790 | -12 | -0.4% | 154,900 |
2025/03/21 | 2,780 | 2,816 | 2,780 | 2,802 | +24 | +0.9% | 106,000 |
2025/03/19 | 2,770 | 2,790 | 2,767 | 2,778 | +8 | +0.3% | 64,700 |
2025/03/18 | 2,765 | 2,776 | 2,755 | 2,770 | +10 | +0.4% | 121,100 |
2025/03/17 | 2,762 | 2,783 | 2,756 | 2,760 | -2 | -0.1% | 75,200 |
2025/03/14 | 2,730 | 2,780 | 2,725 | 2,762 | +11 | +0.4% | 115,300 |
2025/03/13 | 2,791 | 2,791 | 2,735 | 2,751 | -58 | -2.1% | 151,900 |
2025/03/12 | 2,692 | 2,819 | 2,688 | 2,809 | +97 | +3.6% | 249,800 |
2025/03/11 | 2,740 | 2,757 | 2,672 | 2,712 | -70 | -2.5% | 197,800 |
2025/03/10 | 2,821 | 2,828 | 2,773 | 2,782 | -39 | -1.4% | 150,200 |
2025/03/07 | 2,857 | 3,050 | 2,781 | 2,821 | -71 | -2.5% | 547,200 |
2025/03/06 | 2,929 | 2,953 | 2,876 | 2,892 | -30 | -1% | 102,500 |
1~
50
件表示中 / 6955件
類似銘柄と比較する
現在ご覧いただいている「東和薬品」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
東和薬品 | 296,300円 | +7.9% | -3.3% | 2.70% | 8.24倍 | 0.85倍 |
|
後発医薬品メーカーで国内2強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.46倍 |
|
JT傘下。柱の抗HIV薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
科研薬 | 372,400円 | -6.4% | -71.8% | 5.10% | 41.47倍 | 0.92倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の2本柱。後発品も展開 |
ジーエヌアイ | 252,300円 | +21.7% | +999.9% | 0.00% | 10.51倍 | 3.48倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
ゼリア新薬 | 212,700円 | +3.1% | -6.5% | 2.26% | 9.87倍 | 1.05倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム